ESTRELLA IMMUNOPHARMA, INC. Investment Income, Dividend
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Investment Income, Dividend of $114.31 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-01.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeDividend · last filed 2023-08-01
- ESTRELLA IMMUNOPHARMA, INC. investment income, dividend for the quarter ending 2023-06-30 was $114.31K, a 78.11% increase year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. investment income, dividend for the quarter ending 2023-03-31 was $105.79K, a 2768.49% increase year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. investment income, dividend for the quarter ending 2022-06-30 was $64.18K.
- ESTRELLA IMMUNOPHARMA, INC. investment income, dividend for the quarter ending 2022-03-31 was $3.69K.
| Period end | Investment Income, Dividend 3 month | Investment Income, Dividend 6 month |
|---|---|---|
| 2023-06-30 | $114.31K 10-Q · filed 2023-08-01 | $220.10K 10-Q · filed 2023-08-01 |
| 2023-03-31 | $105.79K 10-Q · filed 2023-05-18 | |
| 2022-06-30 | $64.18K 10-Q · filed 2023-08-01 | $67.87K 10-Q · filed 2023-08-01 |
| 2022-03-31 | $3.69K 10-Q · filed 2023-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |